120 related articles for article (PubMed ID: 17053959)
1. The significance of the furosemide test for predicting ascites control by diuretics in cirrhotics: a comparison with volume expansion and octreotide infusion.
Toniutto P; Pirisi M; Fabris C; Apollonio L; Sereti K; Bartoli EG
Dig Dis Sci; 2006 Nov; 51(11):1992-7. PubMed ID: 17053959
[TBL] [Abstract][Full Text] [Related]
2. The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites.
Misra VL; Vuppalanchi R; Jones D; Hamman M; Kwo PY; Kahi C; Chalasani N
Aliment Pharmacol Ther; 2010 Oct; 32(8):1044-50. PubMed ID: 20937051
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
4. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
Spahr L; Villeneuve JP; Tran HK; Pomier-Layrargues G
Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
[TBL] [Abstract][Full Text] [Related]
5. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
[TBL] [Abstract][Full Text] [Related]
6. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
[TBL] [Abstract][Full Text] [Related]
7. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
[TBL] [Abstract][Full Text] [Related]
8. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: comparison with furosemide.
Bernardi M; De Palma R; Trevisani F; Santini C; Patrono D; Motta R; Servadei D; Gasbarrini G
Hepatology; 1986; 6(3):400-5. PubMed ID: 3519416
[TBL] [Abstract][Full Text] [Related]
10. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
Gerbes AL; Bertheau-Reitha U; Falkner C; Jüngst D; Paumgartner G
J Hepatol; 1993 Mar; 17(3):353-8. PubMed ID: 8315263
[TBL] [Abstract][Full Text] [Related]
11. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
[TBL] [Abstract][Full Text] [Related]
12. Effects of "body compression" on parameters related to ascites formation: therapeutic trial in cirrhotic patients.
Uemura M; Matsumoto M; Tsujii T; Fukui H; Miyamoto Y; Kojima H; Kikuchi E; Fukui K; Fujimoto M; Mitoro A; Matsumura M; Takaya A
J Gastroenterol; 1999 Feb; 34(1):75-82. PubMed ID: 10204614
[TBL] [Abstract][Full Text] [Related]
13. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis.
Aliaga L; Zozoya JM; Omar M; Mediavilla JD; Prieto J
Acta Gastroenterol Belg; 1995; 58(2):213-21. PubMed ID: 7571982
[TBL] [Abstract][Full Text] [Related]
14. Oral furosemide-induced natriuresis: a potential method for identifying cirrhotic patients with refractory ascites.
Kountouras J; Zavos C; Touloumis L; Chatzopoulos D
Liver Int; 2010 Oct; 30(9):1395; author reply 1395-6. PubMed ID: 20731771
[No Abstract] [Full Text] [Related]
15. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
[TBL] [Abstract][Full Text] [Related]
16. Continuous furosemide infusion in the management of ascites.
Rogers NA; Gupta S; Cuthbert JA
J Investig Med; 2012 Apr; 60(4):671-5. PubMed ID: 22373660
[TBL] [Abstract][Full Text] [Related]
17. Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.
Salerno F; Borroni G; Lorenzano E; Solenghi D; Cazzaniga M; Bissoli F; Ceriani R; deFranchis R
Hepatology; 1996 May; 23(5):1135-40. PubMed ID: 8621145
[TBL] [Abstract][Full Text] [Related]
18. The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis.
Assy N; Kayal M; Mejirisky Y; Gorenberg M; Hussein O; Schlesinger S
BMC Gastroenterol; 2006 Nov; 6():39. PubMed ID: 17134488
[TBL] [Abstract][Full Text] [Related]
19. Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention.
Carstens J; Grønbaek H; Larsen HK; Pedersen EB; Vilstrup H
BMC Gastroenterol; 2007 Jan; 7():1. PubMed ID: 17257428
[TBL] [Abstract][Full Text] [Related]
20. Propranolol in the treatment of cirrhotic ascites.
Rector WG; Reynolds TB
Arch Intern Med; 1984 Sep; 144(9):1761-3. PubMed ID: 6476994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
